⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TARS News
Tarsus Pharmaceuticals, Inc. Common Stock
Bay Area Lyme Foundation Raises $900,000 at LymeAid 2026, Presenting Inaugural Neil L. Spector, MD, Legacy Award and $300,000 in Emerging Leader Grants
globenewswire.com
PFE
TARS
TNXP
Tarsus and John Cena Partner to Raise Awareness of Demodex blepharitis, a Common Eyelid Disease Affecting Approximately 25 Million Americans
globenewswire.com
TARS
Tarsus to Participate in Upcoming Investor Conferences
globenewswire.com
TARS
Form 8-K
sec.gov
TARS
Tarsus Reports First Quarter 2026 Financial Results and Recent Business Achievements
globenewswire.com
TARS
Tarsus to Report First Quarter 2026 Financial Results on Wednesday, May 6, 2026
globenewswire.com
TARS
TP-03 (lotilaner ophthalmic solution) 0.25% Now Approved in China for the Treatment of Demodex Blepharitis, Triggering a $15M Milestone Payment to Tarsus
globenewswire.com
TARS
Tarsus to Participate in Upcoming Investor Conferences
globenewswire.com
TARS
Form 8-K
sec.gov
TARS
Tarsus Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Business Achievements
globenewswire.com
TARS